DFCM
DYN icon

Dark Forest Capital Management’s Dyne Therapeutics DYN Stock Holding History

Dark Forest Capital Management’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-68,888
Closed -$871K – 1072
2025
Q3 		$871K Buy
68,888
+47,604
+224% +$543K 0.03% 788
2025
Q2 		$203K Sell
21,284
-87,090
-80% -$959K 0.01% 1089
2025
Q1 		$1.13M Buy
+108,374
New +$1.55M 0.05% 629
2024
Q4 		– Sell
-9,307
Closed -$334K – 1036
2024
Q3 		$334K Buy
+9,307
New +$370K 0.04% 561

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Dark Forest Capital Management's DYN Position: Q4 2025 in Review

Dark Forest Capital Management sold out of Dyne Therapeutics (DYN) in Q4 2025, closing a stake of 68,888 shares — an estimated $871K sold.

Dark Forest Capital Management first reported a position in DYN in Q3 2024 and held it in 4 quarters. The position peaked at $1.13M in Q1 2025. 232 funds tracked by Wall St. Rank hold DYN as of Q4 2025.

  • Dark Forest Capital Management reported no remaining Dyne Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Dark Forest Capital Management sold 68,888 Dyne Therapeutics shares in Q4 2025, an estimated $871K.
  • Dark Forest Capital Management first reported a position in Dyne Therapeutics in Q3 2024 and held it in 4 quarters.
  • Dark Forest Capital Management's Dyne Therapeutics position peaked at $1.13M in Q1 2025.
  • 232 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q4 2025.

Based on Dark Forest Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.